Product
BC3195
Name
BC3195
1 clinical trial
3 drugs
1 indication
Indication
Metastatic Solid TumorsDrug
AspirinDrug
CaffeineDrug
SalicylamideClinical trial
A Phase Ia/Ib, Open-Label, First-in-human, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BC3195 in Patients With Locally Advanced or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2025-06-01